Type 2 diabetes mellitus (T2DM) is one of the common metabolic diseases in the world. Due
to the rise in morbidity and mortality, it has become a global health problem. To date, T2DM …

The gut microbiota plays a fundamental role in human nutrition and metabolism and may
have direct implications for type 2 diabetes and associated preconditions. An improved …

Previous microbiome and metabolome analyses exploring non-communicable diseases
have paid scant attention to major confounders of study outcomes, such as common, pre …

Desulfovibrio (DSV) are sulfate-reducing bacteria (SRB) that are ubiquitously present in the
environment and as resident commensal bacteria within the human gastrointestinal tract …

Cardiovascular disease (CVD) remains the most common cause of death worldwide and
has become a public health concern. The proven notable risk factors for CVD are …

Purpose As the treatment regimens such as metformin could confound the correlation
between type 2 diabetes (T2D) and gut microbiome, we should revisit the relationship …

OBJECTIVE Type 1 diabetes is associated with compositional differences in gut microbiota.
To date, no microbiome studies have been performed in maturity-onset diabetes of the …

The gut microbiome and intestinal dysfunction have emerged as potential contributors to the
development of cardiovascular disease (CVD). Alterations in gut microbiome are well …

The intestine is colonized by a considerable community of microorganisms that cohabits
within the host and plays a critical role in maintaining host homeostasis. Recently …

Elevated circulating concentrations of the gut bacteria choline metabolite trimethylamine N‐
oxide (TMAO) were found in patients with type 2 diabetes mellitus (T2DM). However …